Trial site
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny Nr 1 Im. Norberta Barlickiego Uniwersytetu Medycznego W Lodzi
- 34running trials
- 16closed trials
The trials here
What the 50 trials at this site are about, from their registry records.
- Conditions
- Idiopathic pulmonary fibrosis12 trials
- Asthma10 trials
- Crohn's disease4 trials
- ANCA-associated vasculitis3 trials
- Chronic spontaneous urticaria3 trials
- COPD3 trials
- Ulcerative colitis3 trials
- Bronchiectasis2 trials
- Chronic kidney disease2 trials
- Cystic fibrosis2 trials
- Atrial fibrillation1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- and 11 more
- Phase
- Phase 228 trials
- Phase 320 trials
- Phase 42 trials
- Status
- Completed16 trials
- Recruiting13 trials
- Active, not recruiting12 trials
- Not yet recruiting9 trials
- Lead sponsor
- Chiesi Farmaceutici S.p.A.4 trials
- Takeda4 trials
- Avalyn Pharma Inc.3 trials
- Sanofi3 trials
- AstraZeneca2 trials
- and 29 more
Running trials
Not yet recruiting
Not yet recruiting
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Not yet recruiting
Recruiting
Recruiting
Recruiting
Suspended
Recruiting
Recruiting
Recruiting
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Recruiting
Active, not recruiting
A Study Evaluating Monthly (Every 4 Weeks) Dosing of Atacicept in Patients with IgAN
Recruiting
An Open-Label Extension Study of Subjects who Received an Avalyn Inhaled Antifibrotic Agent
Recruiting
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Recruiting
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Active, not recruiting
A trial to evaluate efficacy and safety of buloxibutid in people with idiopathic pulmonary fibrosis
Active, not recruiting
A Phase 2 Study of Obexelimab in Patients with Systemic Lupus Erythematosus
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma6 recruiting
- Idiopathic pulmonary fibrosis6 recruiting
- Crohn's disease3 recruiting
- ANCA-associated vasculitis1 recruiting
- Atrial fibrillation1 recruiting
- Bronchiectasis1 recruiting
- Chronic kidney disease1 recruiting
- Chronic spontaneous urticaria1 recruiting
- COPD1 recruiting
- Cystic fibrosis1 recruiting
- Nephrotic syndrome1 recruiting
- Primary biliary cholangitis1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Withdrawn
Completed
Completed
Terminated
Recruiting
Completed
Completed
Completed
An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Completed
Completed
Completed
Completed
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
Completed
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Terminated
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026